+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

Influenza A Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Influenza A Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
From
Topical Skin Infection Treatment Market - Product Thumbnail Image

Topical Skin Infection Treatment Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
H1N1 Infection - Pipeline Insight, 2025 - Product Thumbnail Image

H1N1 Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
From
From
From
From
From
Antifungals Market Report 2025 - Product Thumbnail Image

Antifungals Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Antivirals Market Report 2025 - Product Thumbnail Image

Antivirals Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Vancomycin Market Report 2025 - Product Thumbnail Image

Vancomycin Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more